Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies, has raised $134 million in financing. The investors include the SBI Group, Japan and Rakuten Inc.
Source: Press Release
Biotech company Rakuten Aspyrian pulls in $134 mln
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.